Will Spooren

Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche

Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.

From this contributor

Spectrum

By Ingrid Wickelgren

13 October 2015

6 min read

Questions for Will Spooren: Paving a path to autism drugs

A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.

Spectrum

Questions for Will Spooren: Paving a path to autism drugs

By Ingrid Wickelgren

13 October 2015 | 6 min read

Explore more from The Transmitter

Spectrum

By Holly Barker

8 October 2026

6 min read

Stock illustration of strands of DNA with mutations.

Number of autism-linked genes more than triples in new analyses

In addition to a new preprint that expands the list of genes tied to the condition, two related analyses reveal how variants in those genes contribute to genetic susceptibility.

Spectrum

Number of autism-linked genes more than triples in new analyses

In addition to a new preprint that expands the list of genes tied to the condition, two related analyses reveal how variants in those genes contribute to genetic susceptibility.

By Holly Barker

8 October 2026 | 6 min read

Brain Inspired

By Paul Middlebrooks

7 October 2026

By clicking to watch this video, you agree to our privacy policy.

How does a control theorist explain cognition?

Maxim Raginsky draws on control theory, engineering and philosophy to explore what makes biological brains intelligent, what artificial intelligence is missing, and what principles underlie biological autonomy.